ConductScience.org, home

Paper889685

Cell survival in B16 melanoma after treatment with combinations of cytotoxic agents: lack of potentiation.

Stephens TC and 2 others. Br J Cancer, 1977. Cited by 33 papers, by iCite.

Cite this record

ConductScience Library. Cell survival in B16 melanoma after treatment with combinations of cytotoxic agents: lack of potentiation. Papers, record 889685. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/889685

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cell survival in B16 melanoma after treatment with combinations of cytotoxic agents: lack of potentiation.
PubMed
Journal
Br J Cancer
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
33
iCite
Relative citation ratio, by iCite
1.83
iCite
Revised in PubMed
2019-05-15
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Stephens TCT C
2Peacock JHJ H
3Steel GGG G

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Cell SurvivalMajor topic
MelanomaMajor topic
Animals
Cyclophosphamide
Dose-Response Relationship, Drug
Drug Synergism
Fluorouracil
Gamma Rays
Mice
Mice, Inbred C57BL
Time Factors
Vincristine

Source PubMed

Download CSV of topics

References13

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114142189THE RADIATION SENSITIVITY OF TRANSPLANTED LYMPHOMA CELLS AS DETERMINED BY THE SPLEEN COLONY METHOD.Radiat Res1964https://conductscience.org/library/papers/14142189PubMed
25097154Combined effect of x radiation and 5-fluorouracil on survival of transplanted leukemic cells.J Natl Cancer Inst1971https://conductscience.org/library/papers/5097154PubMed
44703768Brief communication: polyene potentiation of antitumor agents.J Natl Cancer Inst1973https://conductscience.org/library/papers/4703768PubMed
54121931Response of solid tumor cells exposed to chemotherapeutic agents in vivo: cell survival after 2- and 24-hour exposure.J Natl Cancer Inst1973https://conductscience.org/library/papers/4121931PubMed
64133899Combination therapy with drugs and radiation.Br Med Bull1973https://conductscience.org/library/papers/4133899PubMed
746777Morphological basis for the cytolytic effect of vinblastine and vincristine on cultured human leukemic lymphoblasts.Cancer Res1975https://conductscience.org/library/papers/46777PubMed
84842737Optimum time sequence for the administration of vincristine and cyclophosphamide in vivo.Cancer Res1974https://conductscience.org/library/papers/4842737PubMed
94810905Schedule-dependent synergism for the combination of 1-beta-D-arabinofuranosylcytosine and daunorubicin.Cancer Res1974https://conductscience.org/library/papers/4810905PubMed
104822988Chemotherapy after synchronization of tumor cells.Semin Hematol1974https://conductscience.org/library/papers/4822988PubMed
114823906Synergistic effect of amphotericin B and 1,3-bis(2-chloroethyl)-1-nitrosourea against a transplantable AKR leukemia.Cancer Res1974https://conductscience.org/library/papers/4823906PubMed
12782495A soft agar colony assay for Lewis lung tumour and B16 melanoma taken directly from the mouse.Br J Cancer1976https://conductscience.org/library/papers/782495PubMed
131120304The response of hypoxic B16 melanoma cells to in vivo treatment with chemotherapeutic agents.Cancer Res1975https://conductscience.org/library/papers/1120304PubMed
141131822The enhanced cytotoxicity of combinations of 1-beta-D-arabinofuranosylcytosine and methotrexate.Cancer Res1975https://conductscience.org/library/papers/1131822PubMed

Download CSV of references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.

PMIDTitleJournalYearIn PapersSource
7903668Response of a multidrug-resistant human small-cell lung cancer xenograft to chemotherapy.J Cancer Res Clin Oncol1993https://conductscience.org/library/papers/7903668PubMed
7191713Plasminogen activator in cultured Lewis lung carcinoma cells measured by chromogenic substrate assay.Br J Cancer1980https://conductscience.org/library/papers/7191713PubMed
6932938Comparison of growth delay and cell survival as end-points of tumour response following treatment with combinations of cytotoxic agents.Br J Cancer Suppl1980https://conductscience.org/library/papers/6932938PubMed
6351884Advantage of reduced oxygen tension in growth of human melanomas in semi-solid cultures: quantitative analysis.Br J Cancer1983https://conductscience.org/library/papers/6351884PubMed
2527217Comparative antitumor activity of 5-fluorouracil and 5'-deoxy-5-fluorouridine in combination with radiation therapy in mice bearing colon 26 adenocarcinoma.Jpn J Cancer Res1989https://conductscience.org/library/papers/2527217PubMed
2324161Responses of a murine B16 melanoma to pharmacotherapy studied and compared with different assay systems.J Cancer Res Clin Oncol1990https://conductscience.org/library/papers/2324161PubMed
921888Tumour volume response, initial cell kill and cellular repopulation in B16 melanoma treated with cyclophosphamide and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.Br J Cancer1977https://conductscience.org/library/papers/921888PubMed
743490Influence of anaesthetics on tumour-cell kill and repopulation in B16 melanoma treated with melphalan.Br J Cancer1978https://conductscience.org/library/papers/743490PubMed
728348Cell yield and cell survival following chemotherapy of the B16 melanoma.Br J Cancer1978https://conductscience.org/library/papers/728348PubMed
588423Clonogenic assays in the B16 melanoma: response to cyclophosphamide.Br J Cancer1977https://conductscience.org/library/papers/588423PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/889685

GET https://conductscience.org/api/papers/v1/889685/authors